当前位置: X-MOL 学术Circ. J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Impact of Cardiovascular Disease on Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19).
Circulation Journal ( IF 3.3 ) Pub Date : 2020-07-22 , DOI: 10.1253/circj.cj-20-0348
Yangjing Xie 1 , Qinghai You 2 , Chaoran Wu 1 , Shiyu Cao 1 , Guangbo Qu 3 , Xiaoxiang Yan 4 , Xuan Han 5 , Changhui Wang 1 , Hong Zhang 6
Affiliation  

Background:To investigate the effect of cardiovascular disease (CVD) on the global pandemic, coronavirus disease 2019 (COVID-19), we analyzed the cases of laboratory-confirmed COVID-19 patients in Wuhan.

Methods and Results:Data were extracted from the medical records. SARS-CoV-2 RNA was confirmed by RT-PCR. A total of 33 (53.2%) of 62 cases with CVD, who had higher prevalence of severe COVID-19 compared with non-CVD patients (P=0.027). The median age of all patients was 66.0 (53.3, 73.0) years old. Coronary artery disease (11.3%) and hypertension (38.7%) were the common coexisting CVDs in COVID-19 patients. High-sensitivity cardiac troponin I (hs-cTnI), creatinine, high-density lipoprotein-cholesterol, interleukin-6, C-reactive protein, prothrombin time, and D-dimer levels in the severe COVID-19 with CVD group were higher than in the non-severe COVID-19 with CVD group (P<0.05). For all patients, chest computed tomography (CT) showed ground-glass opacity (66.1%), local (21.0%), bilateral (77.4%), and interstitial abnormalities (4.8%). In COVID-19 patients with CVD, 27 (81.8%) were cured and discharged. 6 (18.2%) remained in hospital, including 2 (3.2%) patients requiring intubation and mechanical ventilation. The hs-cTnI levels in the remaining hospitalized patients were higher than in the discharged patients (P=0.047).

Conclusions:CVDs play a vital role in the disease severity of COVID-19. COVID-19 could result in myocardial injury, which affects the prognosis of COVID-19.



中文翻译:

心血管疾病对2019年冠状病毒病(COVID-19)的临床特征和结果的影响。

背景:为研究心血管疾病(CVD)对全球大流行性冠状病毒病2019(COVID-19)的影响,我们分析了武汉市经实验室确认的COVID-19患者的病例。

方法和结果:从病历中提取数据。通过RT-PCR确认SARS-CoV-2 RNA。在62例CVD患者中,共有33例(53.2%)与非CVD患者相比,严重COVID-19的患病率更高(P = 0.027)。所有患者的中位年龄为66.0(53.3,73.0)岁。冠状动脉疾病(11.3%)和高血压(38.7%)是COVID-19患者常见的CVD。严重的COVID-19伴CVD组的高敏感性心脏肌钙蛋白I(hs-cTnI),肌酐,高密度脂蛋白胆固醇,白介素-6,C反应蛋白,凝血酶原时间和D-二聚体水平高于在非严重COVID-19合并CVD组中(P <0.05)。对于所有患者,胸部计算机断层扫描(CT)均显示出玻璃杯混浊(66.1%),局部(21.0%),双侧(77.4%)和间质异常(4.8%)。在COVID-19的CVD患者中,治愈出院27例(81.8%)。仍有6名(18.2%)住院,包括2名(3.2%)需要插管和机械通气的患者。其余住院患者的hs-cTnI水平高于出院患者(P = 0.047)。

结论: CVD在COVID-19的疾病严重程度中起着至关重要的作用。COVID-19可能导致心肌损伤,从而影响COVID-19的预后。

更新日期:2020-08-23
down
wechat
bug